Ask AI
ASCO 2024 lung cancer WC

CME

Conference to Clinic: Lung Cancer

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Released: July 02, 2024

Expiration: July 01, 2025

Pretest

Progress
1 2
Course Completed
1.

Which of the following findings was reported from the phase III ADRIATIC trial comparing durvalumab vs placebo as consolidation therapy in patients with LS-SCLC without PD following SoC concurrent chemoradiotherapy?

2.

How often do you currently test patients with unresectable stage IIIA-IIIC NSCLC for actionable EGFR mutations?